Your browser doesn't support javascript.
loading
Spatially organized multicellular immune hubs in human colorectal cancer.
Pelka, Karin; Hofree, Matan; Chen, Jonathan H; Sarkizova, Siranush; Pirl, Joshua D; Jorgji, Vjola; Bejnood, Alborz; Dionne, Danielle; Ge, William H; Xu, Katherine H; Chao, Sherry X; Zollinger, Daniel R; Lieb, David J; Reeves, Jason W; Fuhrman, Christopher A; Hoang, Margaret L; Delorey, Toni; Nguyen, Lan T; Waldman, Julia; Klapholz, Max; Wakiro, Isaac; Cohen, Ofir; Albers, Julian; Smillie, Christopher S; Cuoco, Michael S; Wu, Jingyi; Su, Mei-Ju; Yeung, Jason; Vijaykumar, Brinda; Magnuson, Angela M; Asinovski, Natasha; Moll, Tabea; Goder-Reiser, Max N; Applebaum, Anise S; Brais, Lauren K; DelloStritto, Laura K; Denning, Sarah L; Phillips, Susannah T; Hill, Emma K; Meehan, Julia K; Frederick, Dennie T; Sharova, Tatyana; Kanodia, Abhay; Todres, Ellen Z; Jané-Valbuena, Judit; Biton, Moshe; Izar, Benjamin; Lambden, Conner D; Clancy, Thomas E; Bleday, Ronald.
Afiliación
  • Pelka K; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.
  • Hofree M; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Chen JH; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Pathology, MGH, Boston, MA, USA.
  • Sarkizova S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Pirl JD; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Jorgji V; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA; Department of Pathology, MGH, Boston, MA, USA.
  • Bejnood A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Dionne D; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ge WH; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Xu KH; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.
  • Chao SX; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Department of Biomedical Informatics, HMS, Boston, MA, USA.
  • Zollinger DR; NanoString Technologies Inc., Seattle, WA, USA.
  • Lieb DJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Reeves JW; NanoString Technologies Inc., Seattle, WA, USA.
  • Fuhrman CA; NanoString Technologies Inc., Seattle, WA, USA.
  • Hoang ML; NanoString Technologies Inc., Seattle, WA, USA.
  • Delorey T; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Nguyen LT; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Waldman J; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Klapholz M; Evergrande Center for Immunologic Diseases, HMS and Brigham and Women's Hospital (BWH), Boston, MA, USA.
  • Wakiro I; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Cohen O; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA; Department of Medical Oncology, DFCI, Boston, MA, USA.
  • Albers J; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Smillie CS; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Cuoco MS; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wu J; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Su MJ; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Yeung J; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Vijaykumar B; Department of Immunology, HMS, Boston, MA, USA.
  • Magnuson AM; Department of Immunology, HMS, Boston, MA, USA.
  • Asinovski N; Department of Immunology, HMS, Boston, MA, USA.
  • Moll T; Clinical Research Center, MGH, Boston, MA, USA.
  • Goder-Reiser MN; Clinical Research Center, MGH, Boston, MA, USA.
  • Applebaum AS; Clinical Research Center, MGH, Boston, MA, USA.
  • Brais LK; Clinical Research Center, DFCI, Boston, MA, USA.
  • DelloStritto LK; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Denning SL; Clinical Research Center, DFCI, Boston, MA, USA.
  • Phillips ST; Clinical Research Center, MGH, Boston, MA, USA.
  • Hill EK; Clinical Research Center, DFCI, Boston, MA, USA.
  • Meehan JK; Clinical Research Center, DFCI, Boston, MA, USA.
  • Frederick DT; Clinical Research Center, MGH, Boston, MA, USA.
  • Sharova T; Clinical Research Center, MGH, Boston, MA, USA.
  • Kanodia A; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Todres EZ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Jané-Valbuena J; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Biton M; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Molecular Biology, MGH, Boston, MA, USA.
  • Izar B; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Center for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA; Department of Medical Oncology, DFCI, Boston, MA, USA.
  • Lambden CD; Evergrande Center for Immunologic Diseases, HMS and Brigham and Women's Hospital (BWH), Boston, MA, USA.
  • Clancy TE; Department of Surgery, BWH, Boston, MA, USA.
  • Bleday R; Department of Surgery, BWH, Boston, MA, USA.
Cell ; 184(18): 4734-4752.e20, 2021 09 02.
Article en En | MEDLINE | ID: mdl-34450029
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos